CD274 and neoplasm: On the other hand, immunotherapies such as immune checkpoint inhibitors (ICI) attempt to strengthen the immune response of the TME through the elimination of specific molecular programs (such as programmed death-1 (PD1)/ programmed death ligand-1 (PDL1) or α-CTLA4) crucial for the immune escape of tumor cells [8].